Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETN for Fetal Growth Restriction Prophylaxis
NCT03669185Phase 3Unknown
- Sponsor
- Universitätsklinikum Jena
- Start
- Jul 2017
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pentaerythrityl tetranitrate in fetal growth restriction (FGR), sponsored by Universitätsklinikum Jena. Status: unknown.
02
Drugs
pentaerythrityl tetranitrate
03
Conditions
fetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT03669185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03669185.